Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
HealthTech

AccelerateCreate Software

AccelerateCreate Software raises $462M Series E at $1.3B valuation

$462M
Total Raised
Series E
Latest Round
2019
Founded
462+
Employees
Chicago, IL
Updated January 8, 2025
3 min read

Quick Facts

Valuation
$1.3B
Latest Round Size
$462M
Latest Round Date
January 2025

AccelerateCreate Software: Scaling HealthTech Innovation

AccelerateCreate Software has secured $462M in Series E funding, achieving a valuation of $1.3B. The investment round was led by Kleiner Perkins, with participation from Lightspeed Venture Partners.

Company Overview

Founded in 2019 and headquartered in Chicago, IL, AccelerateCreate Software is transforming the healthtech landscape through innovative technology and a customer-first approach. The company has established itself as a key player in the rapidly growing healthtech market.

Product & Market Position

AccelerateCreate Software's platform addresses critical challenges in healthtech by leveraging advanced technology to deliver scalable, efficient solutions. The company serves a diverse customer base ranging from startups to Fortune 500 enterprises.

Funding Details & Investor Confidence

This Series E round brings AccelerateCreate Software's total funding to over $462M, reflecting strong investor confidence in the company's vision and execution. Kleiner Perkins led the round, citing AccelerateCreate Software's impressive growth metrics and market opportunity as key factors in the investment decision.

Growth Metrics & Traction

The company has demonstrated strong product-market fit with rapid customer adoption and consistent revenue growth. Key metrics include expanding customer base, improving retention rates, and increasing average contract values across all customer segments.

Use of Funds

AccelerateCreate Software plans to deploy the capital across several strategic initiatives:

  • Product Development: Expanding platform capabilities and introducing new features
  • Team Expansion: Hiring across engineering, sales, and customer success
  • Market Expansion: Entering new geographic markets and customer segments
  • Infrastructure: Scaling technology infrastructure to support growth

Market Opportunity

The healthtech market is experiencing significant growth, with industry analysts projecting substantial expansion over the next five years. AccelerateCreate Software is well-positioned to capture market share through its differentiated technology and go-to-market strategy.

Competitive Landscape

In an increasingly competitive healthtech sector, AccelerateCreate Software differentiates through superior technology, customer experience, and operational efficiency. The company's platform offers unique capabilities that address unmet market needs.

Leadership & Team

The AccelerateCreate Software leadership team brings extensive experience from leading technology companies and deep domain expertise in healthtech. This combination of technical excellence and industry knowledge positions the company for continued success.

Technology & Innovation

AccelerateCreate Software continues to invest heavily in research and development, with a focus on emerging technologies including artificial intelligence, machine learning, and automation to enhance platform capabilities and deliver superior value to customers.

Customer Success

Customer satisfaction and success remain central to AccelerateCreate Software's strategy. The company maintains high Net Promoter Scores and strong retention rates, reflecting the value delivered through its platform and services.

Future Roadmap

Looking ahead, AccelerateCreate Software plans to accelerate product innovation, expand into adjacent markets, and strengthen its position as a category leader in healthtech. The company is committed to sustainable growth and long-term value creation.

Industry Impact

AccelerateCreate Software's success demonstrates the transformative potential of technology in healthtech. As the company scales, it continues to set new standards for innovation, customer service, and operational excellence in the industry.

Key Investors

Kleiner Perkins
Lead Investor
Strategic investment in healthtech sector
Lightspeed Venture Partners
Co-Lead
Strategic investment in healthtech sector

Topics

HealthTech(503)startup funding(297)venture capital(278)AccelerateCreate SoftwareSeries Etech investment462M

About the Author

Michael Rodriguez
Michael Rodriguez
Fintech and AI specialist with 10+ years covering Silicon Valley funding rounds

Related Company Reports

HealthTech
Abridge

Abridge Raises $150M Series C to Transform HealthTech

Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...

Emma Rodriguez
Emma Rodriguez
Oct 22, 2025
0 min read•$150M Series C
HealthTech
Innovaccer

Innovaccer Raises $275M Series F to Transform HealthTech

Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...

Emma Rodriguez
Emma Rodriguez
Oct 22, 2025
0 min read•$275M Series F
HealthTech
Truveta

Truveta Raises $95M Series B to Transform HealthTech

Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...

Michael Torres
Michael Torres
Oct 22, 2025
0 min read•$95M Series B